{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:01:11Z","timestamp":1781276471497,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.taap.2023.116625","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T21:19:31Z","timestamp":1689196771000},"page":"116625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2\/NOX4\/ERK\/HuR pathway"],"prefix":"10.1016","volume":"474","author":[{"given":"Yuan-Chin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ting","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2023.116625_bb0005","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","article-title":"Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides","volume":"105","author":"Aichberger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.taap.2023.116625_bb0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/15548627.2016.1145325","article-title":"Lysosomal putative RNA transporter SIDT2 mediates direct uptake of RNA by lysosomes","volume":"12","author":"Aizawa","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2023.116625_bb0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41419-021-03542-w","article-title":"Exovesicular-Shh confers Imatinib resistance by upregulating Bcl2 expression in chronic myeloid leukemia with variant chromosomes","volume":"12","author":"Anusha","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2023.116625_bb0020","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2023.116625_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1180","article-title":"Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells","volume":"8","author":"Carter","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.taap.2023.116625_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.taap.2015.02.005","article-title":"Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK\/c-Jun-mediated BCL2L1 expression","volume":"284","author":"Changchien","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2023.116625_bb0035","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1002\/jcp.30407","article-title":"NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells","volume":"236","author":"Chiou","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.taap.2023.116625_bb0040","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrm2256","article-title":"ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis","volume":"8","author":"D\u2019Autr\u00e9aux","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.taap.2023.116625_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0092-8674(02)00972-8","article-title":"Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage","volume":"111","author":"Deverman","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.taap.2023.116625_bb0050","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.freeradbiomed.2011.06.033","article-title":"Cross talk between mitochondria and NADPH oxidases","volume":"51","author":"Dikalov","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2023.116625_bb0055","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1002\/jcp.29724","article-title":"miRNAs, oxidative stress, and cancer: a comprehensive and updated review","volume":"235","author":"Ebrahimi","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.taap.2023.116625_bb0060","first-page":"9","article-title":"Beyond DNA binding - a review of the potential mechanisms mediating quinacrine\u2019s therapeutic activities in parasitic infections, inflammation, and cancers","volume":"15","author":"Ehsanian","year":"2011","journal-title":"Cell Commun. Sig."},{"key":"10.1016\/j.taap.2023.116625_bb0065","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/1541-7786.MCR-10-0325","article-title":"The RNA-binding protein HuR promotes glioma growth and treatment resistance","volume":"9","author":"Filippova","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.taap.2023.116625_bb0070","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1159\/000322105","article-title":"Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy","volume":"32","author":"Fu","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.taap.2023.116625_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.498","article-title":"A novel acridine derivative, LS-1-10 inhibits autophagic degradation and triggers apoptosis in colon cancer cells","volume":"8","author":"Fu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2023.116625_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41419-021-04453-6","article-title":"Sidt2 is a key protein in the autophagy-lysosomal degradation pathway and is essential for the maintenance of kidney structure and filtration function","volume":"13","author":"Geng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2023.116625_bb0085","first-page":"15776","article-title":"Recent developments in the synthesis and biological activity of acridine\/acridone analogues","volume":"7","author":"Gensicka-Kowalewska","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.taap.2023.116625_bb0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.stem.2012.12.011","article-title":"A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition","volume":"12","author":"Goff","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.taap.2023.116625_bb0095","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/onc.2008.460","article-title":"9-Aminoacridine-based anticancer drugs target the PI3K\/AKT\/mTOR, NF-\u03baB and p53 pathways","volume":"28","author":"Guo","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2023.116625_bb0100","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/leu.2013.151","article-title":"Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target","volume":"27","author":"Harb","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.taap.2023.116625_bb0105","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1080\/15548627.2020.1712109","article-title":"Cytosolic domain of SIDT2 carries an arginine-rich motif that binds to RNA\/DNA and is important for the direct transport of nucleic acids into lysosomes","volume":"16","author":"Hase","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2023.116625_bb0110","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.191.6.977","article-title":"Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL","volume":"191","author":"Horita","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2023.116625_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.taap.2017.08.019","article-title":"Quinacrine induces the apoptosis of human leukemia U937 cells through FOXP3\/miR-183\/\u03b2-TrCP\/SP1 axis-mediated BAX upregulation","volume":"334","author":"Huang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2023.116625_bb0120","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.taap.2023.116625_bb0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.taap.2023.116625_bb0130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","article-title":"AP-1 function and regulation","volume":"9","author":"Karin","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.taap.2023.116625_bb0135","doi-asserted-by":"crossref","first-page":"11576","DOI":"10.1158\/0008-5472.CAN-07-2756","article-title":"MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells","volume":"67","author":"Kawano","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2023.116625_bb0140","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1021\/bi201159b","article-title":"Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions","volume":"51","author":"Ketron","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.taap.2023.116625_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1368","article-title":"Hallmarks of cancer and AU-rich elements","volume":"8","author":"Khabar","year":"2017","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.taap.2023.116625_bb0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4161\/cc.10.3.14713","article-title":"ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks","volume":"10","author":"Khalil","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.taap.2023.116625_bb0155","doi-asserted-by":"crossref","first-page":"36354","DOI":"10.18632\/oncotarget.5632","article-title":"Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth","volume":"6","author":"Khurana","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2023.116625_bb0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/hep.26659","article-title":"Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224","volume":"59","author":"Lan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2023.116625_bb0165","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10495-016-1307-5","article-title":"Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1","volume":"22","author":"Lee","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.taap.2023.116625_bb0170","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jcp.24481","article-title":"Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)\/MMP-9 expression in human leukemia cells","volume":"229","author":"Liu","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.taap.2023.116625_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-017-0751-3","article-title":"The Jun\/miR-22\/HuR regulatory axis contributes to tumourigenesis in colorectal cancer","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.taap.2023.116625_bb0180","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1074\/jbc.M109.086231","article-title":"Perturbation of the Bcl-2 network and an induced Noxa\/Bcl-xL interaction trigger mitochondrial dysfunction after DNA damage","volume":"285","author":"Lopez","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2023.116625_bb0185","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/leu.2016.42","article-title":"High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia","volume":"30","author":"Lucas","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.taap.2023.116625_bb0190","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41419-021-04154-0","article-title":"Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells","volume":"12","author":"Malyukova","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2023.116625_bb0195","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Mar\u00e9chal","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.taap.2023.116625_bb0200","article-title":"Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease","volume":"3","author":"Masyuk","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.taap.2023.116625_bb0205","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1038\/sj.onc.1206716","article-title":"The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases","volume":"22","author":"Milosevic","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2023.116625_bb0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.semcancer.2019.09.021","article-title":"Repurposing quinacrine for treatment-refractory cancer","volume":"68","author":"Oien","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.taap.2023.116625_bb0215","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.3390\/cancers14143300","article-title":"Mechanisms of resistance and implications for treatment strategies in chronic myeloid leukaemia","volume":"14","author":"Poudel","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.taap.2023.116625_bb0220","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1039\/C8MD00384J","article-title":"Medicinal chemistry of acridine and its analogues","volume":"9","author":"Prasher","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.taap.2023.116625_bb0225","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1002\/cncr.27568","article-title":"Reverse phase protein array profiling reveals distinct proteomic signatures associated with chronic myeloid leukemia progression and with chronic phase in the CD34-positive compartment","volume":"118","author":"Quint\u00e1s-Cardama","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.taap.2023.116625_bb0230","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2023.116625_bb0235","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.embor.7400536","article-title":"Bcr is a negative regulator of the Wnt signalling pathway","volume":"6","author":"Ress","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.taap.2023.116625_bb0240","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130067","article-title":"Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?","volume":"33","author":"Rumjanek","year":"2013","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.taap.2023.116625_bb0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10637-012-9854-2","article-title":"Efficacy of substituted 9-aminoacridine derivatives in small cell lung cancer","volume":"31","author":"Ryan","year":"2013","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.taap.2023.116625_bb0250","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1038\/onc.2011.168","article-title":"Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study","volume":"30","author":"Shen","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2023.116625_bb0255","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/cancers13092004","article-title":"Quinacrine-induced autophagy in ovarian cancer triggers cathepsin-l mediated lysosomal\/mitochondrial membrane permeabilization and cell death","volume":"13","author":"Thirusangu","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.taap.2023.116625_bb0260","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/524308","article-title":"The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias","volume":"2012","author":"Tzifi","year":"2012","journal-title":"Adv. Hematol."},{"key":"10.1016\/j.taap.2023.116625_bb0265","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/molecules28010193","article-title":"Acridine as an anti-tumour agent: a critical review","volume":"28","author":"Varakumar","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2023.116625_bb0270","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-8166-3-15","article-title":"Genomic amplification of BCR\/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines","volume":"3","author":"Virgili","year":"2010","journal-title":"Mol. Cytogenet."},{"key":"10.1016\/j.taap.2023.116625_bb0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis*","volume":"43","author":"Wang","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.taap.2023.116625_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114865","article-title":"Docetaxel-triggered SIDT2\/NOX4\/JNK\/HuR signaling axis is associated with TNF-\u03b1-mediated apoptosis of cancer cells","volume":"195","author":"Wang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2023.116625_bb0285","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s001090050063","article-title":"Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways","volume":"74","author":"Whitmarsh","year":"1996","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.taap.2023.116625_bb0290","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood.2021014689","article-title":"Asciminib: a new therapeutic option in chronic-phase CML with treatment failure","volume":"139","author":"Yeung","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.taap.2023.116625_bb0295","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1039\/C5TX00419E","article-title":"MiR-146a affects the alteration in myeloid differentiation induced by hydroquinone in human CD34+ hematopoietic progenitor cells and HL-60 cells","volume":"5","author":"Yuan","year":"2016","journal-title":"Toxicol Res. (Camb.)"},{"key":"10.1016\/j.taap.2023.116625_bb0300","first-page":"209","article-title":"Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development","volume":"52","author":"Zwelling","year":"1992","journal-title":"Cancer Res."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23002648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23002648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:04:33Z","timestamp":1758575073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X23002648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":60,"alternative-id":["S0041008X23002648"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2023.116625","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2\/NOX4\/ERK\/HuR pathway","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2023.116625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116625"}}